Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

Title: Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop
Authors: de Ruiter R. D.; Smilde B. J.; Pals G.; Bravenboer N.; Knaus P.; Schoenmaker T.; Botman E.; Sanchez-Duffhues G.; Pacifici M.; Pignolo R. J.; Shore E. M.; van Egmond M.; Van Oosterwyck H.; Kaplan F. S.; Hsiao E. C.; Yu P. B.; Bocciardi R.; De Cunto C. L.; Longo Ribeiro Delai P.; de Vries T. J.; Hilderbrandt S.; Jaspers R. T.; Keen R.; Koolwijk P.; Morhart R.; Netelenbos J. C.; Rustemeyer T.; Scott C.; Stockklausner C.; ten Dijke P.; Triffit J.; Ventura F.; Ravazzolo R.; Micha D.; Eekhoff E. M. W.
Contributors: de Ruiter, R. D.; Smilde, B. J.; Pals, G.; Bravenboer, N.; Knaus, P.; Schoenmaker, T.; Botman, E.; Sanchez-Duffhues, G.; Pacifici, M.; Pignolo, R. J.; Shore, E. M.; van Egmond, M.; Van Oosterwyck, H.; Kaplan, F. S.; Hsiao, E. C.; Yu, P. B.; Bocciardi, R.; De Cunto, C. L.; Longo Ribeiro Delai, P.; de Vries, T. J.; Hilderbrandt, S.; Jaspers, R. T.; Keen, R.; Koolwijk, P.; Morhart, R.; Netelenbos, J. C.; Rustemeyer, T.; Scott, C.; Stockklausner, C.; ten Dijke, P.; Triffit, J.; Ventura, F.; Ravazzolo, R.; Micha, D.; Eekhoff, E. M. W.
Publisher Information: Frontiers Media S.A.; CHE
Publication Year: 2021
Collection: Università degli Studi di Genova: CINECA IRIS
Subject Terms: angiogenesi; disease model; fibrodysplasia ossificans progessiva (FOP); inflammation; therapy; trials
Description: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare progressive genetic disease effecting one in a million individuals. During their life, patients with FOP progressively develop bone in the soft tissues resulting in increasing immobility and early death. A mutation in the ACVR1 gene was identified as the causative mutation of FOP in 2006. After this, the pathophysiology of FOP has been further elucidated through the efforts of research groups worldwide. In 2015, a workshop was held to gather these groups and discuss the new challenges in FOP research. Here we present an overview and update on these topics.
Document Type: article in journal/newspaper
File Description: ELETTRONICO
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/34858325; info:eu-repo/semantics/altIdentifier/wos/WOS:000725178000001; volume:12; firstpage:732728-1; lastpage:732728-12; numberofpages:12; journal:FRONTIERS IN ENDOCRINOLOGY; https://hdl.handle.net/11567/1067573
DOI: 10.3389/fendo.2021.732728
Availability: https://hdl.handle.net/11567/1067573; https://doi.org/10.3389/fendo.2021.732728
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.367CB00E
Database: BASE